Hypertension in children after renal transplantation

Current Hypertension Reviews

Volumn 3, Issue 1, 2007, Pages 59-68

  Seeman, Tomáš ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Angiotensin converting enzyme inhibitors; Blood pressure control; Children; Graft function; Graft survival; Hypertension; Renal transplantation

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LISINOPRIL; LOOP DIURETIC AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIFEDIPINE; RAMIPRIL; RAPAMYCIN; STEROID; TACROLIMUS; THIAZIDE DIURETIC AGENT;

ACUTE GRAFT REJECTION; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHILDHOOD MORTALITY; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; FOCAL GLOMERULOSCLEROSIS; GENETIC POLYMORPHISM; GRAFT FAILURE; GRAFT SURVIVAL; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; KIDNEY ARTERY STENOSIS; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; NEPHRECTOMY; NEPHROTOXICITY; OBESITY; PEDIATRIC SURGERY; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; WEIGHT GAIN;

EID: 34247126891     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340207779815545     Document Type: Review

References (97)

1. Midtvedt K, Neumayer HH. Management strategies for posttransplant hypertension. Transplantation 2000; 70: SS64-9.
2. Baluarte HJ, Gruskin AB, Ingelfinger JR, Stablein D, Tejani A. Analysis of hypertension in children post renal transplantation - a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 1994; 8: 570-3.
3. Sorof JM, Sullivan EK, Tejani A, Portman RJ. Antihypertensive medication and renal allograft failure: A North American Pediatric Renal Transplant Cooperative Study report. J Am Soc Nephrol 1999; 10: 1324-30.
4. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158-65.
5. Tutone VK, Mark PB, Stewart GA, et al. Hypertension, antihypertensive agents and outcomes following renal transplantation. Clin Transplant 2005; 19: 181-92.
6. Opelz G, Wujciak T, Ritz E for the Collaborative Transplant Study. Association of chronic kidney graft failure with recipient blood pressure. Kidney Int 1998; 53: 217-22.
7. Mange KC, Gizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA 2000; 283: 633-8.
8. Schwenger V, Zeier M, Ritz E. Hypertension after renal transplantation. Curr Hypertens Rep 2001; 5: 434-9.
9. Mitsnefes MM, Omoloja A, McEnery PT. Short-term pediatric renal transplant survival: Blood pressure and allograft function. Pediatr Transpl 2001; 5: 160-5.
10. Mitsnefes MM, Khoury PR, McEnery PT. Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr 2003; 143: 98-103.
11. Calzolari A, Giordano U, Matteucci MC, et al. Hypertension in young patients after renal transplantation, ambulatory blood pressure monitoring versus casual blood pressure. Am J Hypert 1998; 11: 497-501.
12. Mitsnefes MM, Portman RJ. Ambulatory blood pressure monitoring in pediatric renal transplantation. Pediatr Transplant 2003; 7: 86-92.
13. Jacobi J, Rockstroh J, John S, et al. Prospective analysis of the value of 24-hour ambulatory blood pressure on renal function after kidney transplantation. Transplantation. 2000; 70: 819-27.
14. Bald M, Bohm W, Feldhoff C, Bonzel KE. Home blood pressure self-measurement in children and adolescents with renal replacement therapy. Klin Padiatr 2001; 213: 21-5.
15. Wühl E, Hadtstein C, Mehls O, Schaefer F for Escape Trial Group. Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatr Res 2004; 55: 492-7.
16. Nagasako SS, Koch Nogueira PC, Machado PGP. Arterial hypertension following renal transplantation in children - a short-term study. Pediatr Nephrol 2003; 18: 1270-4.
17. Lingens N, Dobos E, Witte K, et al. Twenty-four-hour ambulatory blood pressure profiles in pediatric patients after renal transplantation. Pediatr Nephrol 1997; 11: 23-6.
18. Matteucci MC, Giordano U, Calzolari A, Turchetta A, Santilli A, Rizzoni G. Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients. Kidney Int 1999; 56: 1566-70.
19. Giordano U, Matteucci MC, Calzolari A, Turchetta A, Rizzoni G, Alpert BS. Ambulatory blood pressure monitoring in children with aortic coarctation and kidney transplantation. J Pediatr 2000; 136: 520-3.
20. Sorof JM, Poffenbarger T, Portman R. Abnormal 24-hour blood pressure patterns in children after renal transplantation. Am J Kidney Dis 2000; 35: 681-6.
21. Morgan H, Khan I, Hashmi A, Hebert D, McCrindle BW, Balfe JW. Ambulatory blood pressure monitoring after renal transplantation in children. Pediatr Nephrol 2001; 16: 843-7.
22. Serdaroglu E, Mir S, Berdelli A. Hypertension and ACE gene insertion/ deletion polymorphism in pediatric renal transplant patients. Pediatr Transplant 2005; 9: 612-7.
23. Seeman T, Dušek J, Vondrák K, et al. Ambulatory blood pressure monitoring in children after renal transplantation. Transplant Proc 2004; 36: 1355-6.
24. Seeman T, Šimková E, Kreisinger J, et al. Control of hypertension in children after renal transplantation. Pediatr Transplant 2006; 10: 316-22.
25. Soergel M, Kirschstein M, Busch C, et al. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: A multicenter trial including 1141 subjects. J Pediatr 1997; 130: 178-84.
26. Kim HC, Kwon JK, Park SB, Cho WH, Park CH. Hypertension in kidney transplantation recipients: effect on long-term renal allograft survival. Transplant Proc 1998; 30: 3906-7.
27. Ponticelli C, Montagnino G, Aroldi A, Angelini C, Braga M, Tarantino A. Hypertension after renal transplantation. Am J Kidney Dis 1993; 5(Suppl 2): 73-8.
28. Vianello A, Mastrosimone S, Calconi G, Gatti PL, Calzavara P, Maresca MC. The role of hypertension as damaging factor for kidney grafts under cyclosporine therapy. Am J Kidney Dis 1993; 21 (Suppl 1): 79-83.
29. Morales JM. Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Kidney Int 2002; 62: S81-7.
30. Lipkin GW, Tucker B, Giles M, Raine AE. Ambulatory blood pressure and left ventricular mass in cyclosporin- and non-cyclosporin-treated renal transplant recipients. J Hypertens 1993; 11: 439-42.
31. Gordjani A, Offner G, Hoyer PF, Brodehl J. Hypertension after renal transplantation in patients treated with cyclosporine and azathioprine. Arch Dis Child 1990; 65: 275-9.
32. Tejani A. Post-transplant hypertension and hypertensive encephalopathy in renal allograft recipients. Nephron 1983; 34: 73-8.
33. Budde K, Waiser J, Fritsche L, et al. Hypertension in patients after renal transplantation. Transplant Proc 1997; 29: 209-11.
34. Pérez Fontán K. Rodríguez-Carmona, A, Garcia Falcón T, Fernández Rivera C, Valdés F. Early immunological and nonimmunological predictors of arterial hypertension after renal transplantation. Am J Kidney Dis 1999; 33: 21-5.
35. Curtis JJ, Diethelm AG, Jones P, Luke RG, Whelchel JD. Benefits of removal of native kidney in hypertension after renal transplantation. Lancet 1985; 2: 739-42.
36. Vanrenterghem Y, Waer M, Christiaens MR, Michielsen P. Bilaterial nephrectomy of the native kidneys reduces the incidence of arterial hypertension and erythrocytosis in kidney graft recipients treated with cyclosporine. Leuven Collaborative Group for Transplantation. Transpl Int 1992; 5(Suppl 1): S35-7.
37. Kasiske BL, Ballantyne CM. Cardiovascular risk associated with immunosuppression in renal transplantation. Transplant Rev 2002; 16: 1-21.
38. Inguli E, Tejani A, Markell M. The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children post-transplantation in the cyclosporine era. Transplantation 1993; 55: 1029-33.
39. Hocker B, John U, Plank C, et al. Successful withdrawal of steroids in pediatrics renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years. Transplantation 2004; 78: 228-34.
40. Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O Jr. Continued superior outcome with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003; 76: 1331-9.
41. Curtis JJ, Galla JH, Kotchen TA, Lucas B, McRoberts JW, Luke RG. Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy. Clin Nephrol 1976; 5: 123-7.
42. Broyer M, Guest G, Gagnadoux MF, Beurton D. Hypertension following renal transplantation in children. Pediatr Nephrol 1987; 1: 16-21.
43. Kahan BD, Flechner SM, Lorber MI, Golden D, Conley S, Van BCT. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years. Transplantation 1987; 43: 197-204.
44. Curtis JJ. Hypertension following kidney transplantation. Am J Kidney Dis 1994; 23: 471-5.
45. Büscher R, Vester U, Wingen AM, Hoyer PF. Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients. Pediatr Nephrol 2004; 19; 1202-11.
46. Mihatsch MJ, Kyo M, Morozumi K, Yamaguchi Y, Nickeleit V, Ryffel B. The side-effects of ciclosporine-A and tacrolimus. Clin Nephrol 1998; 49: 356-63.
47. Zeier M, Dikow R, Ritz E. Blood pressure after renal transplantation. Annals Transplant 2001; 6: 21-4.
48. First MR, Neylan JF, Rocher LL, Tejani A. Hypertension after renal transplantation. J Am Soc Nephrol 1994; 4: S30-6.
49. Trompeter R, Filler G, Webb NJ, et al. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol 2002; 17: 141-9.
50. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS for the FK506 Kidney Transplant Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997; 63: 977-83.
51. Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: Evidence for improved allograft survival at five years. Transplantation 2002; 73: 775-82.
52. Margreiter R. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomized multicentre study. The European Tacrolimus vs Ciclosporin-Microemulsion Renal Transplantation Study Group. Lancet 2002; 359: 741-6.
53. Cheigh JS, Haschemeyer RH, Wang JCL, et al. Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival. Am J Hypertens 1989; 2: 341-8.
54. Fernández-Fresnedo G, Palomar R, Escallada R, et al. Hypertension and long-term renal allograft survival: effect of early glomerular filtration rate. Nephrol Dial Transplant 2001; 16(Suppl 1):105-9.
55. Warholm C, Wilczek H, Pettersson E. Hypertension two years after renal transplantation: causes and consequences. Transpl Int 1995; 8: 286-92.
56. Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension 2002; 40: 441-7.
57. Lurbe E, Alvarez V, Liao Y, et al. The impact of obesity and body fat distribution on ambulatory blood pressure in children and adolescents. Am J Hypertens 1998; 11: 418-24.
58. Hanevold CD, Ho PL, Talley L, Mitsnefes MM. Obesity and renal transplant outcome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 2005; 115: 352-6.
59. Meier-Kriesche HU, Vaghela M, Thambuganipalle R, Friedman G, Jacobs M, Kaplan B. The effect of body mass in index on long-term renal allograft survival. Transplantation 1999; 68: 1294-7.
60. Moreso F, Seron D, Anunciada AI, et al. Recipients body surface area as a predictor of post transplant renal allograft evolution. Transplantation 1998; 65: 671-6.
61. Fontaine E, Barthelemy Y, Gagnadoux MF, Cokier J, Broyer M, Beurtron D. A review of 72 renal artery stenosis in a series of 715 kidney transplantation in children. Prog Urol 1994; 4: 193-205.
62. Fung LC, McLorie GA, Khoury AR, Churchill BM. Donor aortic cuff reduces the rate of anastomotic arterial stenosis in pediatric renal transplantation. J Urol 1995; 154: 909-3.
63. Bruno S, Remuzzi G, Ruggenenti P. Transplant renal artery stenosis. J Am Soc Nephrol 2004; 15: 134-41.
64. Montagnino G, Tarantino A. Banfi G, Maccario M, Costamagna L, Ponticelli C. Double recurrence of FSGS after two renal transplants with complete regression after plasmapheresis and ACE inhibitors. Transpl Int 2000; 13: 166-8.
65. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992; 92: 375-83.
66. Guyton AC. Blood pressure control - special role of the kidneys and body fluids. Science 1991; 252(5014):1813-16.
67. Rettig R, Bandelow N, Patachan O, Kuttler B, Frey B, Uber A. The importance of the kidney in primary hypertension: Insights from cross-transplantation. J Hum Hypertens 1996; 10: 641-4.
68. Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P, Dietheim AG. Remission of essential hypertension after renal transplantation. N Engl J Med 1983; 309: 1009-14.
69. Guidi E, Bianchi G, Rivolta E. Hypertension in man with a kidney transplantation: Role of familial versus other factors. Nephrol 1985; 41: 14-21.
70. Filler G, Yang F, Martin A. Stolpe J, Neumayer HH, Hocher B. Renin angiotensin system gene polymorphisms in pediatric renal transplant recipients. Pediatr Transplant 2001; 5: 166-73.
71. Mitsnefes MM, Kimball TR, Border WL, et al. Abnormal cardiac function in children after renal transplantation. Am J Kidney Dis 2004; 43: 721-6.
72. Kitzmueller E, Vćsei A, Pichler J, et al. Changes of blood pressure and left ventricular mass in pediatric renal transplantation. Pediatr Nephrol 2004; 19: 1385-9.
73. Groothoff JW, Gruppen MP, Offringa M, et al. Mortality and causes of death of end-stage renal diseases in children: a Dutch cohort study. Kidney Int 2002; 61: 621-9.
74. Berber I, Aydin C, Yigit B, et al. Blood pressure and graft outcome in renal transplantation. Transplant Proc 2005; 37: 997-8.
75. Akioka K, Takahara S, Ichikawa S, Yoshimura N, Akiyama T, Ohshima S. Factors predicting long-term graft survival after kidney transplantation: Multicenter study in Japan. World J Surg 2005; 29: 249-56.
76. Jafar TH, Stark PC, Schmid CH, et al. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 2001; 60: 1131-40.
77. Hohage H, Kleyer U, Brückner D, August C, Zidek W, Spieker C. Influence of proteinuria on long-term transplant survival in kidney transplant recipients. Nephron 1997; 75: 160-5.
78. Roodnat JI, Mulder PG, Rischen-Vos J, et al. Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation 2001; 72: 438-444.
79. Seeman T, Simková E, Kreisinger J, et al. Proteinuria in children after renal transplantation. Transplant Proc 2005; 37: 4282-3.
80. Ruggenenti P, Perna A, Mosconi L, et al. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 1993; 43: 706-11.
81. Curtis JJ. Treatment of hypertension in renal allograft patients: Does drug selection make a difference. Kidney Int 1997; 52(Suppl 63): S75-7.
82. Midtvedt K, Ihlen H, Hartmann A, et al. Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study. Transplantation 2001; 72: 107-11.
83. Stigant CE, Cohen J, Vivera M, Zaltzman JS. ACE inhibitors and angiotensin H antagonists in renal transplantation: an analysis of safety and efficacy. Am J Kidney Dis 2000; 35: 58-63.
84. Arbeiter K, Pichler A, Stemberger R, et al. ACE inhibition in the treatment of children after renal transplantation. Pediatr Nephrol 2004; 19: 222-6.
85. Ruggenenti P, Perna A, Gheradi G, Gaspari F, Benigni I, Remuzzi G. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Lancet 1998; 352: 1352-6.
86. Tejani A, Sullivan EK. The impact of acute rejection on chronic rejection: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2000; 4: 107-11.
87. Artz MA, Hilbrands LB, Borm. G, Assmann KJM, Wetzels JFM. Blockade of the renim-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant 2004; 19: 2852-7.
88. Fernández-Fresnedo G, Plaza JJ, Sánchez-Plumed J. Sanz-Guajardo A, Palomar-Fontanet R, Arias M, Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant 2004; 19(Suppl 3): iii47-51.
89. Hausberg M, Barenbrock M, Hohage H, Müller S, Heidenreich S, Rahn KH. ACE inhibitor versus β-blocker for the treatment of hypertension in renal allograft recipients. Hypertension 1999; 33: 862-8.
90. Task force on cardiovascular disease. Special report from the National Kidney Foundation. Am J Kidney Dis 1998; 32(Suppl 3): 1-121.
91. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555-76.
92. Seeman T, Šimková E, Kreisinger J, et al. Improved control of hypertension in children after renal transplantation. Results of a two-year interventional trial. Pediatr Transplant; in press.
93. Opelz G, Dohler B, Collaborative Transplant Study. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 2005; 5: 2725-31.
94. Ruder, H. Renal transplantation in children and adolescents. Monatsschr Kinderheilkd 1996; 144: 951-64.
95. Sorof JM, Goldstein SL, Brower ED, Steiger HM, Portman RJ. Serial estimation of glomerular filtration rate in children after renal transplantation. Pediatr. Nephrol 1999; 13: 737-41.
96. Wigger M, Drückler J, Muscheites J, Stolpe HJ. Course of glomerular filtration rater after renal transplantation and the influence of hypertension. Clin. Nephrol 2001; 56: 30-4.
97. Groothoff JW, Cransberg; K, Offringa M, et al. Long-term follow-up of renal transplantation in children: a Dutch cohort study. Transplantation 2004; 78: 453-60.